LEADER 01271nam0 22003133i 450 
001 VAN00267129
005 20240806101522.84
017 70$20$a9783031063572
100   $a20231116d2022       |0itac50      ba
101   $aeng
102   $aCH
105   $a||||    |||||
200 1 $aPediatric Cancer Therapeutics Development$fJorge DiMartino, Gregory H. Reaman, Franklin O. Smith editors
210   $aCham$cSpringer$d2022
215   $aVI, 181 p.$d24 cm
410  1$1001VAN00111338$12001 $aPediatric Oncology$1210  $aBerlin$cSpringer
620   $aCH$dCham$3VANL001889
702  1$aDiMartino$bJorge$3VANV219801
702  1$aReaman$bGregory H.$3VANV085863
702  1$aSmith$bFranklin O.$3VANV085862
712   $aSpringer <editore>$3VANV108073$4650
801   $aIT$bSOL$c20240906$gRICA
856 4 $uhttps://doi.org/10.1007/978-3-031-06357-2$zE-book - Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth
899   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$2VAN15
912   $fN
912   $aVAN00267129
950   $aBIBLIOTECA CENTRO DI SERVIZIO SBA$d15CONS      SBA EBOOK 11545                     $e15EB 11545             20231116            
996   $aPediatric Cancer Therapeutics Development$92966317
997   $aUNICAMPANIA